Wendy S. Arnold

Net worth: 24 817 $ as of 29/04/2024

52 year

Health Technology

Consumer Services

Profile

Wendy S.
Arnold worked as the Director of Human Resources at Avila Therapeutics, Inc. from 2011 to 2014.
She then worked as the Head of Human Resources at Moderna, Inc. from 2014 to 2017.
In 2018, she became the Senior Vice President of Human Resources at Kaleido Biosciences, Inc. until 2020.
From 2020 to 2023, she served as the Chief People Officer at Frequency Therapeutics, Inc. Ms. Arnold received an undergraduate degree from Colorado State University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
0.00%	25/01/2023	424 ( 0.00% )	24 817 $	29/04/2024

Former positions of Wendy S. Arnold

Companies	Position	End
KORRO BIO, INC.	Human Resources Officer	30/03/2023
KALEIDO BIOSCIENCES, INC.	Human Resources Officer	30/01/2020
MODERNA, INC.	Human Resources Officer	30/11/2017
Avila Therapeutics, Inc. Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ.	Human Resources Officer	31/12/2013

See the detail of Wendy S. Arnold's experience

Training of Wendy S. Arnold

Colorado State University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wendy S. Arnold's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
KALEIDO BIOSCIENCES, INC.	Health Technology
MODERNA, INC.	Health Technology

Private companies	2
Avila Therapeutics, Inc. Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ.	Health Technology
Frequency Therapeutics, Inc. Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA.	Health Technology